摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(tetradecyloxy)benzyl alcohol | 97067-74-8

中文名称
——
中文别名
——
英文名称
3-(tetradecyloxy)benzyl alcohol
英文别名
3-(tetradecyloxy)benzenemethanol;3-tetradecyloxybenzyl alcohol;(3-tetradecoxyphenyl)methanol
3-(tetradecyloxy)benzyl alcohol化学式
CAS
97067-74-8
化学式
C21H36O2
mdl
——
分子量
320.516
InChiKey
CSYLVKFFXDBXDL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    440.7±20.0 °C(Predicted)
  • 密度:
    0.937±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    7.7
  • 重原子数:
    23
  • 可旋转键数:
    15
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.71
  • 拓扑面积:
    29.5
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-(tetradecyloxy)benzyl alcohol吡啶三溴化磷 作用下, 以 乙腈 为溶剂, 以83%的产率得到1-(bromomethyl)-3-(tetradecyloxy)benzene
    参考文献:
    名称:
    Analogs of platelet activating factor. 8. Antagonists of PAF containing an aromatic ring linked to a pyridinium ring
    摘要:
    A series of platelet activating factor (PAF) antagonists containing a quaternary pyridinium ring connected through an amide, imide, or carbamate linkage to a substituted aromatic ring was prepared. Of these compounds, those containing a branched imide linkage of the form (CON-(COCH3)CH2, 37-51, and 59) generally showed excellent PAF antagonist properties in vitro. Structure-activity relationships within this series of compounds were studied extensively with respect to substituents and the position of substitution in both the aromatic and pyridinium rings. Several of these compounds (40 and 44) showed in vitro PAF antagonism at less than 0.1 muM and are as potent as CV-6209, the most potent PAF antagonist reported in the literature. Less active PAF antagonists were those bearing simple amide linkages (20-23, 27-29, and 31-35), linear imide linkages (62-63), or carbamate linkages (66 and 68), between the two aromatic rings. A number of our PAF antagonists were tested in vivo in mice and rabbits for their ability to protect these animals against a lethal injection of PAF. Those antagonists that are particularly potent (IC50 <0.1 muM) provide excellent protection against an LD97 dose of PAF in rabbits. The relationships between structure and activity in vitro and in vivo are presented and compared to literature standards.
    DOI:
    10.1021/jm00057a008
  • 作为产物:
    描述:
    3-(Tetradecyloxy)benzoic acid 在 lithium aluminium tetrahydride 作用下, 以 四氢呋喃 为溶剂, 反应 60.0h, 以98%的产率得到3-(tetradecyloxy)benzyl alcohol
    参考文献:
    名称:
    Analogs of platelet activating factor. 8. Antagonists of PAF containing an aromatic ring linked to a pyridinium ring
    摘要:
    A series of platelet activating factor (PAF) antagonists containing a quaternary pyridinium ring connected through an amide, imide, or carbamate linkage to a substituted aromatic ring was prepared. Of these compounds, those containing a branched imide linkage of the form (CON-(COCH3)CH2, 37-51, and 59) generally showed excellent PAF antagonist properties in vitro. Structure-activity relationships within this series of compounds were studied extensively with respect to substituents and the position of substitution in both the aromatic and pyridinium rings. Several of these compounds (40 and 44) showed in vitro PAF antagonism at less than 0.1 muM and are as potent as CV-6209, the most potent PAF antagonist reported in the literature. Less active PAF antagonists were those bearing simple amide linkages (20-23, 27-29, and 31-35), linear imide linkages (62-63), or carbamate linkages (66 and 68), between the two aromatic rings. A number of our PAF antagonists were tested in vivo in mice and rabbits for their ability to protect these animals against a lethal injection of PAF. Those antagonists that are particularly potent (IC50 <0.1 muM) provide excellent protection against an LD97 dose of PAF in rabbits. The relationships between structure and activity in vitro and in vivo are presented and compared to literature standards.
    DOI:
    10.1021/jm00057a008
点击查看最新优质反应信息

文献信息

  • Bis-arylphosphate ester antagonists of platelet activating factor
    申请人:American Cyanamid Co.
    公开号:US04983592A1
    公开(公告)日:1991-01-08
    The invention is novel compounds of the formula: ##STR1## which are antagonists of platelet activating factor.
    这项发明是一种新型化合物,化学式为:##STR1##,它们是血小板活化因子的拮抗剂。
  • Pyridinium compounds which are useful as antagonists of platelet
    申请人:American Cyanamid Company
    公开号:US05208247A1
    公开(公告)日:1993-05-04
    The invention is aryl, amide, imide and carbamate pyridine antagonists of platelet activating factor.
    这项发明是关于芳基、酰胺、亚酰胺和氨基甲酸吡啶对血小板活化因子的拮抗剂。
  • Aryl pyridinium compounds which are useful in treating shock
    申请人:American Cyanamid Company
    公开号:US05328921A1
    公开(公告)日:1994-07-12
    The invention is aryl, amide, imide and carbamate pyridine antagonists of platelet activating factor.
    这项发明是关于芳基、酰胺、亚酰胺和氨基甲酸吡啶类抗血小板活化因子拮抗剂。
  • Sebosuppressive kosmetische Mittel, enthaltend Alkoxyaryl-alkanole
    申请人:Henkel Kommanditgesellschaft auf Aktien
    公开号:EP0140033A2
    公开(公告)日:1985-05-08
    Sebosuppressive Wirkstoffe in Kosmetika zur Behandlung von fettiger Haut und fettigem Haar sind Alkoxyaryl- alkanole der allgemeinen Formel: R'O in Position 2, 3 oder bevorzugt 4 = Alkyl-(C4-20) R2 = Alkyl-(C1-4),Alkoxy-C1-4), OH oder vorzugsweise H n=0 oder Die Substanzen sind zum Teil neue Verbindungen, die durch katalytische oder chemische Reduktion von entsprechend substituierten Arencarbonsäureestern, Arencarbaldehyden bzw. Arylessigsäureestern oder Arylacetaldehyden mit komplexen Hydriden des Aluminiums oder Bors herstellbar sind.
    用于治疗油性皮肤和油性头发的化妆品中的降脂活性成分是通式如下的烷氧基芳基烷醇 R'O在第 2、3 位或最好是第 4 位=烷基-(C4-20) R2=烷基-(C1-4)、烷氧基-C1-4)、OH 或最好是 H n=0 或 这些物质部分是新化合物,可以通过催化或化学还原相应取代的苯甲酸酯、苯乙醛或芳基乙酸酯或芳基乙醛与铝或的复合氢化物来制备。
  • Novel bis-arylphosphate ester antagonists of platelet activating factor
    申请人:AMERICAN CYANAMID COMPANY
    公开号:EP0374513A2
    公开(公告)日:1990-06-27
    The invention is novel compounds of the formula: which are antagonists of platelet activating factor.
    本发明是式中的新型化合物: 是血小板活化因子的拮抗剂。
查看更多

同类化合物

(R)-3-(叔丁基)-4-(2,6-二异丙氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (2S,3R)-3-(叔丁基)-2-(二叔丁基膦基)-4-甲氧基-2,3-二氢苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2R,2''R,3R,3''R)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2-氟-3-异丙氧基苯基)三氟硼酸钾 (+)-6,6'-{[(1R,3R)-1,3-二甲基-1,3基]双(氧)}双[4,8-双(叔丁基)-2,10-二甲氧基-丙二醇 麦角甾烷-6-酮,2,3,22,23-四羟基-,(2a,3a,5a,22S,23S)- 鲁前列醇 顺式6-(对甲氧基苯基)-5-己烯酸 顺式-铂戊脒碘化物 顺式-四氢-2-苯氧基-N,N,N-三甲基-2H-吡喃-3-铵碘化物 顺式-4-甲氧基苯基1-丙烯基醚 顺式-2,4,5-三甲氧基-1-丙烯基苯 顺式-1,3-二甲基-4-苯基-2-氮杂环丁酮 非那西丁杂质7 非那西丁杂质3 非那西丁杂质22 非那西丁杂质18 非那卡因 非布司他杂质37 非布司他杂质30 非布丙醇 雷诺嗪 阿达洛尔 阿达洛尔 阿莫噁酮 阿莫兰特 阿维西利 阿索卡诺 阿米维林 阿立酮 阿曲汀中间体3 阿普洛尔 阿普斯特杂质67 阿普斯特中间体 阿普斯特中间体 阿托西汀EP杂质A 阿托莫西汀杂质24 阿托莫西汀杂质10 阿托莫西汀EP杂质C 阿尼扎芬 阿利克仑中间体3 间苯胺氢氟乙酰氯 间苯二酚二缩水甘油醚 间苯二酚二异丙醇醚 间苯二酚二(2-羟乙基)醚 间苄氧基苯乙醇 间甲苯氧基乙酸肼 间甲苯氧基乙腈 间甲苯异氰酸酯